CHICAGO (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman's claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Following the lead of French pharmaceutical giant Sanofi, Pfizer has agreed to settle more than 10,000 personal-injury claims from users of heartburn drug Zantac, resolving litigation in several U.S.

A woman who claimed in a lawsuit that GSK’s discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the ...

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK (GSK.L), opens new tab and other companies, causes cancer is set to begin this week in Chicago ...

The verdict, in a case brought by plaintiff Angela Valadez, comes two years after a federal judge tossed all the plaintiffs' experts in the Zantac multidistrict litigation. Additional Zantac jury ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.